FDA approval pathways for products claiming to prevent or reverse aging

Science published a Policy Forum in which researchers argue that longevity products generally fall under existing US regulations, rather than in a regulatory gray area. The authors say challenges to bringing them legally to market are largely scientific, including developing and validating measures that predict longevity benefits. They also call for enforcing legal requirements and requiring rigorous evidence of safety and effectiveness.